The Story

Cellect Biotechnology Ltd. was founded in 2011 by Kasbian Nuriel Chirich, Dr. Shai Yarkoni and Dr. Nadir Ashkenazy with a vision of enabling regenerative medicine to become reality.

 

Realizing that stem cells are one of the pillars of the 21st century medicine, first development was around enabling the mass enrichment of stem cells as a raw material for any and all regenerative treatments. Without such technologies, stem cells based treatments will remain within the confines of laboratories and clinical trials.

 

For regenerative medicine to become publicly available for all people, quality stem cells need to become a commodity, easily available in mass for all medicinal purposes.

 

Cellect was driven by its wish to become the main provider of technologies for pharma companies and medical centers that will make the production of stem cells based products a trivial, safe and inexpensive process.

 

Based on 15 years of in depth research, Cellect's ApoGraft is the long sought-after methodology that achieves that dream. Backed by 7 families of patents, Cellects’ ApoGraft is aimed at becoming the industry-wide standard for enabling the use of stem cells in a myriad of regenerative medicine treatments.

 

Management

Shai Yarkoni | CEO, MD, PhD

Co-Founder


Dr. Yarkoni Has Over 15 Years Of Clinical And Management Experience In The Biopharmaceutical Industry. He Is The Founder Of 5 Start-Ups In The Life-Sciences Field, And Serves On The Board Of Noted Institutes In Israel And The World. Prior To Joining Cellect, He Served As CEO Of Target-In Ltd., And As CTO And VP R&D Of Collgard Biopharmaceutical, A Tissue Therapeutics Company. Dr. Yarkoni Has M.D Ph.D From The Hadassah Medical School, Jerusalem, Israel, And Is A Board Certified Ob/Gyn. Dr. Yarkoni Is The Author Of Over 60 Scientific Papers.

Kasbian Nuriel Chirich | Executive  Chairman

Co-Founder

 

Accomplished Financial / Business Expert Holding Executive Positions In Global Enterprises. Previous Position Founder And General Manager Of Kasbian- LeadCom Tanzania. Operating In East Africa For The Past 15 Years. Mr. Kasbian Is The Honorary Consul Of Tanzania In Israel.

Eyal Leibovitz | CFO

 

Eyal has over 27 years of experience in senior management, finance, IR, M&A and business development in international pharma and biotech companies. acting as CFO of several NASDAQ/NYSE listed companies including Kamada Ltd. NASDAQ:KMDA and Evogene Ltd. NYSE:EVGN).

 

Among his many achievements, he led Kamada to a successful large scale funds raising (including PIPE round, public rights offering, venture lending and public convertible debt) and led the sale of N-trig to Microsoft. In all companies he held full responsibility of all financial reporting, budget control, financial planning, strategic negotiations, IR/PR, legal proceedings, operations and HR.

 

Yaron Pereg | CDO, PhD


Yaron brings unique experience in large scale biotech projects development from his role as Senior Director of Oncology in BioLineRx (NASDAQ:BLRX).

 

Dr. Pereg have worked in the innovative biopharmaceutical industry for over a decade leading worldwide non-clinical and clinical programs of multiple drug development projects managing multi-disciplinary teams and multi-million dollar budgets. He has a diverse experience in pharma and biotech R&D arena including preclinical, regulation, clinical, CMC and operational activities of drug development in the field of Oncology. He has hands-on track-record in preparation of regulatory packages for FDA, EMA and MoH.

 

Prior to BioLineRx, Yaron held Research and Development positions in Genentech Inc., a biotechnology corporation and member of the Roche  Group (ADR: RHHBY) and in the medical-device start-up company Gluesense.

Board of Directors

Together with Cellect Chairman and the CEO

RUTH BEN YAKAR | PhD


Dr. Ben Yakar Has Over 22 Years Of Experience In The Biomedical Field, Including 15 Years Of Management And Leading Diverse Activities. Dr. Ben Yakar Is The CEO Of BioSight, A Clinical-Phase Biotech Company And A Business Consultant To Biomed Companies. She Formerly Served As CEO Of Biotech Companies Procognia And Thrombotech, As The Chief Business Officer Of YEDA, The Technology Transfer Company Of The Weizmann Institute Of Science, And As VP In Several Biotech Companies.

 

YUVAL BERMAN | LL.B, B.A

 

Yuval Is The Founder And Managing Director Of U.V.B Business Initiatives Ltd., A Business Consultancy Firm Based In Tel Aviv. Previously Yuval Worked In The Investment Banking And Underwriting Units Of A Leading Investment Bank And A Publicly Traded Financial Services Group. Yuval Served As A Board Member Of Several Private Companies As Well As A Publicly Traded Group. He Holds LL.B. And B.A. Degrees In Law And Economics From Tel Aviv University And An MBA From The Solvay Business School, Université Libre De Bruxelles.

DUDI GROSSMAN | B.A

 

Mr. Grossman’s Business Experience Includes Venture Capital, Private Equity And Executive Management, Mainly In The Healthcare Arena. He Currently Serves As Chairman Of The Board At Algomizer Ltd. And As An Independent Director At Amnis Therapeutics Ltd. Previously Mr. Grossman Was A Director And The CEO At XTL Biopharmaceuticals Ltd., A Late Stage Drug Development Company. Prior To That He Was VP At Eurocom Investments, And Senior Analyst At Israel Health Care Ventures. Mr. Grossman Also Served As Director In Other Public Companies, Including Ones Traded On AIM And TASE. He holds a B.A. in Business from IDC Herzliya.

ABRAHAM NAHMIAS | C.P.A, B.A

 

Mr. Abraham Nahmias Has Over 30 Years Of Financial Experience Both As A Partner At Nahmias-Grinberg C.P.A. As Well As A Director At 5 Public Companies In Diversified Fields Of Business. Mr. Nahmias Has Earned His B.A In Economics And Accounting From Tel Aviv University Is A Certified Public Accountant By The Accounting Council, Ministry Of Justice, Israel.

Join our mailing list

© Cellect Biosciences Ltd., 2017 All rights reserved

Submitting Form...

The server encountered an error.

Form received. Thank you.

Kasbian Nuriel Chirich

Executive  Chairman

Co-Founder

 

Accomplished Financial / Business Expert Holding Executive Positions In Global Enterprises. Previous Position Founder And General Manager Of Kasbian- LeadCom Tanzania. Operating In East Africa For The Past 15 Years. Mr. Kasbian Is The Honorary Consul Of Tanzania In Israel.